Performance of Commercial Deep Learning-Based Auto-Segmentation Software for Prostate Cancer Radiation Therapy Planning: A Systematic Review
As yet, there is no systematic review focusing on benefits and issues of commercial deep learning-based auto-segmentation (DLAS) software for prostate cancer (PCa) radiation therapy (RT) planning despite that NRG Oncology has underscored such necessity. This article’s purpose is to systematically re...
| Main Author: | |
|---|---|
| Format: | Journal Article |
| Published: |
MDPI
2025
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2078-2489/16/3/215 http://hdl.handle.net/20.500.11937/97316 |